期刊文献+

维甲酸受体及其作用机制研究进展 被引量:8

下载PDF
导出
摘要 维甲酸受体属于核受体超家族中的一个子受体,包括两类子受体家族即RARs和RXRs。维甲酸受体与维甲酸结合后被激活,通过维甲酸信号通路作用于特异性靶基因而发挥不同效应,其治疗机制尚未完全明确。本文综述了维甲酸、维甲酸受体及其分类、维甲酸信号通路、维甲酸受体在皮肤中的表达和功能,以及维甲酸受体的作用机制的研究进展。
作者 杨娟 张锡宝
出处 《皮肤性病诊疗学杂志》 2014年第5期423-426,共4页 Journal of Diagnosis and Therapy on Dermato-venereology
  • 相关文献

参考文献31

  • 1黄帆,刘映孜,杨秋珺,周龙洋,周岐新,罗进勇,何百成,邓忠良.全反式维甲酸增强骨形态蛋白9诱导间充质干细胞成骨分化作用[J].第三军医大学学报,2013,35(4):328-331. 被引量:10
  • 2严昉,陈连军.维甲酸类药物在皮肤科疾病治疗中的应用[J].上海医药,2010,31(4):156-159. 被引量:11
  • 3孙宇强,王雪,关兴芳,李德胜,舒晓宏,李墨林.维甲酸及其受体与肿瘤关系的研究进展[J].生命科学,2014,26(3):295-301. 被引量:15
  • 4Bissonnette R,Worm M,Gerlach B,et al.Successful retreatment with alitretinoin in patients with relapsed chronic hand eczema[J].Br J Dermatol,2010,162(2):420-426.
  • 5Carretero G,Ribera M,Belinchón I,et al.Guidelines for the use of acitretin in psoriasis.Psoriasis Group of the Spanish Academy of Dermatology and Venereology[J].Actas Dermosifiliogr,2013,104(7):598-616.
  • 6Theodosiou M,Laudet V,Schubert M.From carrot to clinic:an overview of the retinoic acid signaling pathway[J].Cell Mol Life Sci,2010,67(9):1423-1445.
  • 7Alizadeh F,Bolhassani A,Khavari A,et al.Retinoids and their biological effects against cancer[J].Int Immunopharmacol,2014,18(1):43-49.
  • 8Gaudreau S,Guindi C,Ménard M,et al.GM-CSF induces bone marrow precursors of NOD mice to skew into tolerogenic dendritic cells that protect against diabetes[J].Cell Immunol,2010,265(1):31-36.
  • 9Das BC,Thapa P,Karki R,et al.Retinoic acid signaling pathways in development and diseases[J].Bioorg Med Chem,2014,22(2):673-683.
  • 10Albalat R.The retinoic acid machinery in invertebrates:ancestral elements and vertebrate innovations[J].Mol Cell Endocrinol,2009,313(1-2):23-35.

二级参考文献73

  • 1Elder Jr,Fischer G J,Zhang QY,et al.Retinoic acid gene receptor expression in human skin[J].J Invest Dermatol,1991,96(4):425-433.
  • 2Gollnick H,Bauer R,Brindley C,et al.Acitretin versus etretinate in psoriasis:Clinical and pharmacokinetic results of a German Multicenter study[J].J Am Acad Dermatol,1988,19(3):458-469.
  • 3Ozawa A,Ohkido M,Haruki Y,et al.Treatment of generalizad pustular psoriasis:A multicenter study in Japan[J].J Dermatol,1999,26(3):141-149.
  • 4Menter A.Pharmacokinetics and safety of tazarotene[J].J Am Acad Dermatol,2000,43(2 Pt 3):31-35.
  • 5Lebwohl M,Ast E,Callen JP,et al.Once-daily tazarotene gel versus twice-daily fluocinonide cream in the treatment of plaque psoriasis[J].J Am Acad Dermatol,1998,38(5 Pt1):705-711.
  • 6Tzung TY,Wu JC,Hsu NJ,et al.Comparison of tazarotene0.1% gel plus petrolatum once daily versus calcipotriol 0.005%ointment twice daily in the treatment of plaque psoriasis[J].Acta Derm Venereol,2005,85(3):236-239.
  • 7Martine C.Retinoid therapy for acne[J].Am J Clin Dermatol,2005,6(1):13-19.
  • 8Lehucher-Ceyrac D,Weber-Buisset MJ.Isotretinoin and ache in practice:A prospective analysis of 188 cases over 9 years[J].Dermatology,1993,186(2):81-82.
  • 9Michel S,Jomard A,Demarchez M.Pharmacology of adapalene[J].Br J Dermatol,1998,139(Suppl 52):3-7.
  • 10Leyden JJ.Topical treatment of acne vulgaris:Retinoids and cutaneous irritation[J].J Am Acad Dermatol,1998,38(4):S1-S4.

共引文献68

同被引文献89

引证文献8

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部